News

Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company ...
Growing threats make it increasingly important for enterprises to deploy advanced cybersecurity software and to understand ...